Sharyn I. Katz Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

John Brown University

faculty

26 h-index 152 pubs 5,438 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Dr. Sharyn I. Katz's research encompasses a range of topics related to lung health, from occupational and environmental lung diseases to the diagnosis, treatment, and genetic underpinnings of lung cancer. A faculty member at John Brown University, Katz applies radiomics and machine learning techniques to medical imaging for improved diagnostic accuracy. Katz's work also explores the effectiveness of various lung cancer treatments, including immunotherapies. Recent publications have investigated the role of CTLA4 blockade in overcoming resistance to PD-(L)1 inhibitors and the utility of circulating tumor DNA monitoring in predicting treatment response. Katz contributed to a consensus statement on imaging malignant pleural mesothelioma.

Metrics

h-index: 26
Publications: 152
Citations: 5,438

Selected Publications

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2025) DOI
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors (2024) DOI
Radiomics Analysis for the Identification of Invasive Pulmonary Subsolid Nodules From Longitudinal Presurgical CT Scans (2024) DOI
Imaging in pleural Mesothelioma: A review of the 16th International Conference of the International Mesothelioma Interest Group (2024) DOI
Abstract 2587: Evaluating the potential of radiomics features to predict outcome to an antibody-drug conjugate therapy in non-small cell lung cancer patients (2024) DOI
State of the art: radiomics and radiomics-related artificial intelligence on the road to clinical translation (2023) DOI
NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI). (2023) DOI
Radiomics analysis to diagnose tumor invasiveness of pulmonary sub-solid nodules from longitudinal pre-surgical CT scans (2023) DOI
Cardiovascular Substructure Dose and Cardiac Events following Proton- and Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer (2023) DOI
Data from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2023) DOI
Data from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2023) DOI
Supplementary Figure Legends from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2023) DOI
Supplementary Methods from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2023) DOI
Supplementary Figures from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2023) DOI
Supplemental Tables from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy (2023) DOI